TEE/Angio Fusion Study

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 2, 2018

Study Completion Date

May 2, 2018

Conditions
Structural Heart Disease
Interventions
DEVICE

Transesophageal Echocardiography/angiography (TEE/Angio)

"The TEE probe will be inserted into the patient's esophagus, after anesthetic induction or conscious sedation is administered, and removed after the completion of the procedure. Once the TEE probe is placed, the interventional cardiologist will acquire 2 fluoroscopic images with the TEE probe. These images will be used to co-register the ultrasound and fluoroscopy systems. As part of routine care, TEE and fluoroscopy images will be acquired throughout the procedure for clinical purposes. As new fluoroscopy images are acquired, the prototype software will automatically track the location of the TEE probe. When the echocardiographer has an image of a cardiac structure of interest, he may use the prototype software to place landmarks.~The echocardiographer may then press a button to have the landmarks displayed on the fluoroscopy image that is only visible on an assist monitor and will not interfere with the standard fluoroscopy imaging monitor."

Trial Locations (1)

10016

New York University Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02737969 - TEE/Angio Fusion Study | Biotech Hunter | Biotech Hunter